Silo Pharma (SILO) News Today $0.63 -0.01 (-1.69%) Closing price 08/29/2025 03:47 PM EasternExtended Trading$0.63 +0.00 (+0.59%) As of 08/29/2025 06:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SILO Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Silo Pharmaâs Alzheimerâs Candidate SPC-14 Featured in Leading Scientific Peer-reviewed Journal August 21, 2025 | markets.businessinsider.comSilo Pharma, Inc. Announces Publication of Preclinical Research on Alzheimer's Therapeutic SPC-14 in Alzheimer’s Research & TherapyAugust 21, 2025 | quiverquant.comQSilo Pharma's Alzheimer's Candidate SPC-14 Featured in Leading Scientific Peer-reviewed JournalAugust 21, 2025 | globenewswire.comSilo Pharma's PTSD Candidate SPC-15 Achieves Positive Safety Milestone, Paving Way for Accelerated Clinical Trials Under 505(b)(2) PathwayAugust 19, 2025 | globenewswire.comSilo Pharma Second Quarter 2025 Earnings: US$0.19 loss per share (vs US$0.30 loss in 2Q 2024)August 15, 2025 | finance.yahoo.comSilo Pharma launches crypto treasury strategy with Bitcoin focusAugust 6, 2025 | investing.comSilo Pharma Appoints Crypto Infrastructure Pioneer Corwin Yu to Launch Institutional Bitcoin, Ethereum and Solana Treasury PlatformAugust 5, 2025 | globenewswire.comSilo Pharma Announces Completion of Dosing in Safety Study of PTSD Drug SPC-15July 16, 2025 | globenewswire.comSilo Pharma Secures Exclusive License for CNS PeptidesJuly 10, 2025 | tipranks.comSilo Pharma, Inc. Plans IND Application Submission for PTSD Drug SPC-15 with Potential Phase 1 Trial in 2026 - NasdaqJuly 9, 2025 | nasdaq.comSilo Pharma Advances PTSD Drug SPC-15 Toward Planned 2025 IND Submission with Pre-Clinical Study Data Expected in Q3 2025July 7, 2025 | globenewswire.comSilo Pharma Faces Nasdaq Non-Compliance NoticeJuly 3, 2025 | msn.comSilo Pharma and Hoth Therapeutics plan joint venture for obesity treatmentJune 26, 2025 | investing.comSilo Pharma Enters into Letter of Intent to Form Joint Venture with Hoth Therapeutics to Develop Obesity Treatment Targeting $16 Billion Global Market - MorningstarJune 26, 2025 | morningstar.comMSilo Pharma and Hoth Therapeutics to Form Joint Venture for VA-Developed Obesity Treatment - NasdaqJune 26, 2025 | nasdaq.comSilo Pharma Enters into Letter of Intent to Form Joint Venture with Hoth Therapeutics to Develop Obesity Treatment Targeting $16 Billion Global MarketJune 25, 2025 | globenewswire.comHoth Therapeutics (HOTH) and Silo Pharma (NASDAQ: SILO) today announced the formation of a 50/50 joint venture to develop a first-in-class GDNF-based therapy licensed from the U.S. Department of Veterans Affairs. The therapy targets obesity and fatty liver disease.June 25, 2025 | prnewswire.comSilo Pharma, Inc.: Silo Pharma Secures Biomarker Patent for Novel PTSD Therapeutic SPC-15 as Clinical Trial NearsJune 11, 2025 | finanznachrichten.deSilo Pharma Secures Biomarker Patent for Novel PTSD Therapeutic SPC-15 as Clinical Trial NearsJune 11, 2025 | globenewswire.comSilo Pharma, Inc. Approves $1 Million Bitcoin Purchase as Treasury Reserve AssetJune 7, 2025 | nasdaq.comSilo Pharma Board of Directors Approves Purchase of Bitcoin as Treasury Reserve AssetJune 5, 2025 | globenewswire.comSilo Pharma, Inc.: Silo Pharma Partners with Resyca for IND-Supporting Intranasal Drug-Device Study of PTSD Drug SPC-15May 23, 2025 | finanznachrichten.deSilo Pharma teams up with Resyca for IND-supporting intranasal drug-device study of PTSD drugMay 21, 2025 | msn.comSilo Pharma Partners with Resyca for IND-Supporting Intranasal Drug-Device Study of PTSD Drug SPC-15May 21, 2025 | globenewswire.comSilo Pharma, Inc.: Silo Pharma Selects Veloxity Labs for Bioanalytical IND-Enabling Study for our Novel Intranasal PTSD Therapy, SPC-15May 16, 2025 | finanznachrichten.deSilo Pharma Signs With Frontage Labs For FDA Requested Safety Study Of SPC-15May 16, 2025 | nasdaq.comSilo Pharma Announces Closing of $2 Million Public OfferingMay 16, 2025 | globenewswire.comSilo Pharma Retail Buzz Surges On FDA Toxicology Study Plans For PTSD TreatmentMay 16, 2025 | msn.comSilo Pharma, Inc. Prices Public Offering of 3,333,338 Shares with Associated WarrantsMay 15, 2025 | quiverquant.comQSilo Pharma Announces Pricing of $2 Million Public OfferingMay 15, 2025 | globenewswire.comSilo Pharma Selects Veloxity Labs for Bioanalytical IND-Enabling Study for our Novel Intranasal PTSD Therapy, SPC-15May 14, 2025 | globenewswire.comSilo Pharma, Inc. Announces Agreement with Frontage Laboratories for SPC-15 Safety and Toxicology Study Targeting PTSD TreatmentMay 14, 2025 | quiverquant.comQSilo Pharma Advances PTSD Drug SPC-15 Toward First-in-Human Trial with Key Safety Study Initiated at Frontage LaboratoriesMay 14, 2025 | globenewswire.comSilo Pharma’s SP-26 Ketamine Implant Meets All Endpoints in Fibromyalgia StudyApril 30, 2025 | finance.yahoo.comSilo Pharma's SP-26 Ketamine Implant Meets All Endpoints in Fibromyalgia StudyApril 30, 2025 | globenewswire.comSilo Pharma Files Patent Application for Alzheimer's Drug SPC-14 Targeting Novel Mechanism of ActionApril 29, 2025 | nasdaq.comSilo Pharma Expands Intellectual Property Portfolio with Patent Application for Exclusively Licensed Alzheimer’s DrugApril 28, 2025 | finance.yahoo.comSilo Pharma Expands Intellectual Property Portfolio with Patent Application for Exclusively Licensed Alzheimer's DrugApril 28, 2025 | globenewswire.comSilo Pharma files to sell 4.72M shares of common stock, warrantsApril 26, 2025 | markets.businessinsider.comSilo Pharma announces first dosing in IND-enabling study for SPC-15March 27, 2025 | markets.businessinsider.comSilo Pharma Achieves Key Milestone with First Dosing in IND-Enabling GLP Study for SPC-15 as a Groundbreaking PTSD TreatmentMarch 26, 2025 | globenewswire.comSilo Pharma Granted U.S. Patent for Novel Intranasal Post-Traumatic Stress Disorder TreatmentFebruary 26, 2025 | globenewswire.comSilo Pharma files provisional patent for SPC-15 combinationFebruary 19, 2025 | markets.businessinsider.comSilo Pharma Expands Intellectual Property Portfolio with Provisional Patent Filing for Innovative SPC-15 Combination TreatmentFebruary 18, 2025 | globenewswire.comSilo Pharma, Inc.: Silo Pharma Announces Positive Initial Pharmacokinetic, Safety, and Tolerability Study of SP-26 for Chronic Pain and FibromyalgiaFebruary 11, 2025 | finanznachrichten.deSilo Pharma reports positive early data on pain treatment implantFebruary 11, 2025 | msn.comSilo Pharma announces initial data from SP-26 studyFebruary 11, 2025 | markets.businessinsider.comSilo Pharma Announces Positive Initial Pharmacokinetic, Safety, and Tolerability Study of SP-26 for Chronic Pain and FibromyalgiaFebruary 11, 2025 | globenewswire.comSilo Pharma files provisional patent for PTSD treatmentJanuary 22, 2025 | msn.comSilo Pharma Advances Intellectual Property Portfolio with Provisional Patent Filing for PTSD TreatmentJanuary 22, 2025 | globenewswire.com Get Silo Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for SILO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SILO Media Mentions By Week SILO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SILO News Sentiment▼1.871.05▲Average Medical News Sentiment SILO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SILO Articles This Week▼11▲SILO Articles Average Week Get the Latest News and Ratings for SILO and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Silo Pharma and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Perfect Moment News Today ON News Today lululemon athletica News Today Amer Sports News Today Birkenstock News Today Levi Strauss & Co. News Today Gildan Activewear News Today Kontoor Brands News Today The Baldwin Insurance Group News Today Ermenegildo Zegna News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SILO) was last updated on 8/30/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredMy NEXT $1 Trillion PredictionJames Altucher is making his next trillion-dollar prediction — and this time, it’s not Apple. He believes Elon...Paradigm Press | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Silo Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Silo Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
